FindTrial
Sign In

Effectiveness and Safety of Single-Branch Covered Sent (Castor™) in Patients with Complex Thoracic Aortic Diseases:a Singe-center Retrospective Study

Effectiveness and Safety of Single-Branch Covered Sent (Castor™) in Patients with Complex Thoracic Aortic Diseases:a Singe-center Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118455
Enrollment
Unknown
Registered
2026-02-05
Start date
2026-02-14
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic aortic dissection, thoracic aortic aneurysm, thoracic aortic intramural hematoma, thoracic aortic ulceration, thoracic aortic intramural hematoma

Interventions

Single-Stent Graft Implantation Group for the Thoracic Aorta:None

Sponsors

First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.All patients diagnosed with TADs underwent TEVAR using Castor stents at our center were included in this study. 2.Complete clinical data.

Exclusion criteria

Exclusion criteria: 1.Incomplete clinical data; 2.loss to follow-up during the follow-up period.

Design outcomes

Primary

MeasureTime frame
Paralumenal remodeling at the tracheal carina and aortic arch;Technical success rate;30-day mortality rate;30-day major adverse event incidence;—

Countries

China

Contacts

Public ContactKai-Xiong QING

First Affiliated Hospital of Kunming Medical University

davidqkx@icloud.com+86 871 6532 4888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026